Skip to content

Efficacy and Safety of Lignopad (5% lignocaine medicated plaster) in Acute Post-operative Pain Management (A Pilot Study)

Efficacy and Safety of Lignopad in Acute Post-operative Pain Management

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16007868
Enrollment
Unknown
Registered
2016-01-29
Start date
2016-02-08
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute post-operative pain

Interventions

Two groups:5% lignocaine medicated plaster (lignopad) 1 patch (700mg) over 24 hours, three days, once a day, versus Placebo 1 patch over 24 hours, three days, once a day

Sponsors

Prince of Wales Hospital, Hospital Authority
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patient 18-60 years old; 2. Planned major abdominal non-malignant gynaecological surgery 3. Planned open midline surgical incision 4. Willing and able to give consent 5. ASA (American Society of Anaesthesiologists) Class 1 to 2.;Inclusion criteria: 1. Patient 18-60 years old; 2. Planned major abdominal non-malignant gynaecological surgery 3. Planned open midline surgical incision 4. Willing and able to give consent 5. ASA (American Society of Anaesthesiologists) Class 1 to 2.

Exclusion criteria

Exclusion criteria: 1. Patient refused either intravenous PCA or lignopad?; 2. Contraindicated to lignopad?: hypersensitivity to local anaesthetics of the amide type; inflamed or injured skin peri-surgical site (e.g. atopic dermatitis, open wounds); 3. Planned transverse or oblique incisional approach; 4. Allergy or tolerance to opiates; 5. Extensive existing midline abdominal scarring; 6. Unable to communicate in English or Chinese.;Exclusion criteria: 1. Patient refused either intravenous PCA or lignopad?; 2. Contraindicated to lignopad?: hypersensitivity to local anaesthetics of the amide type; inflamed or injured skin peri-surgical site (e.g. atopic dermatitis, open wounds); 3. Planned transverse or oblique incisional approach; 4. Allergy or tolerance to opiates; 5. Extensive existing midline abdominal scarring; 6. Unable to communicate in English or Chinese.

Design outcomes

Primary

MeasureTime frame
Difference in mean visual analogue scale (VAS) pain score at rest and on movement at 24 hours after extubation;;Difference in mean visual analogue scale (VAS) pain score at rest and on movement at 24 hours after extubation;

Secondary

MeasureTime frame
Mean visual analogue scale (VAS) pain scores at rest and on movement at 48 and 72 hours after extubation;Intravenous PCA morphine consumption at 24, 48 and 72 hours after extubation;Pre-operative and post-operative peak flow rate difference comparison at 24, 48 and 72 hours extubation;Complications arising from lignopad? application;;Mean visual analogue scale (VAS) pain scores at rest and on movement at 48 and 72 hours after extubation;Intravenous PCA morphine consumption at 24, 48 and 72 hours after extubation;Pre-operative and post-operative peak flow rate difference comparison at 24, 48 and 72 hours extubation;Complications arising from lignopad? application;

Countries

China

Contacts

Public ContactLydia Lau;Lydia Lau ;

Prince of Wales Hospital, Hospital Authority;Prince of Wales Hospital, Hospital Authority

lydialnlau@gmail.com;lydialnlau@gmail.com+852 69018306;+852 69018306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026